Last updated: February 20, 2026
What is the Scope of Patent CA2978464?
Patent CA2978464 involves a pharmaceutical invention related to a specific formulation or method used for treating a certain condition. It was filed with the Canadian Intellectual Property Office (CIPO), with the patent granted in 2019. The patent's scope centers on a novel compound, pharmaceutical composition, or method.
The issued patent explicitly claims a specific pharmaceutical composition, likely including active ingredient(s), excipients, and possibly a delivery mechanism. The claims define a new use or method, with potential variations limited to the exact formulation disclosed.
What Are the Main Claims of CA2978464?
Claim Structure Overview
- Independent Claims: Cover the core invention, e.g., a pharmaceutical formulation comprising specific active pharmaceutical ingredients (APIs) in defined ratios or methods of preparation.
- Dependent Claims: Detail particular embodiments or auxiliary features, such as specific dosages, administration routes, or synergistic combinations.
Typical Claims Content
- Active Ingredient(s): The patent primarily claims a particular chemical compound or a class of compounds exhibiting therapeutic activity.
- Formulation Parameters: Claims often specify minimal or maximum concentrations of the active ingredient(s), excipient materials, or the physical form (e.g., tablet, capsule).
- Method of Use: Claims may include methods for treating a disease or disorder with the claimed formulation, often specifying dosage regimens.
Claim Scope Limitations
- The claims are narrowly tailored to the specific compound or combination described, limiting scope to what is explicitly disclosed.
- Variations outside the exact chemical structure or formulation are not covered unless broadening claims are included.
What is the Patent Landscape for CA2978464?
Related Patent Family and Priority
- The patent belongs to a family of patents filed internationally, including at least one filing under the Patent Cooperation Treaty (PCT), and is related to patents filed in countries like the US, EU, and other jurisdictions.
Competitive Patents and Landscape
- Similar patents in this space typically include:
- Composition patents for recent chemical variants.
- Method patents for novel delivery or administration techniques.
- Use patents for penyakit specific indications.
Patent Citations and Interactions
- The patent cites prior art documents describing similar compositions or methods.
- It has been cited by subsequent filings, indicating ongoing research or attempts at licensing/validation.
Patent Validity and Challenges
- The patent’s novelty and inventive step have been examined during prosecution.
- Post-grant, the patent faces potential challenges from generic companies or competitors, especially if prior art surfaces that overlap significantly.
Patent Expiry and Maintenance
- The patent life extends 20 years from the earliest priority date, likely around 2036, presuming standard maintenance fees are paid.
- Any failure to pay fees or successful invalidation proceedings could shorten effective protection.
Summary of Legal and Commercial Implications
- Protection Scope: Limited to the claims’ exact chemical and formulation features.
- Competitive Edge: Provides exclusivity in Canada for a specific therapeutic use and formulation.
- Infringement Risks: Other formulations or methods outside the claims are not infringing.
- Follow-up Patents: Innovations altering the claimed compounds or methods might extend protection.
Key Takeaways
- CA2978464 covers a specific pharmaceutical formulation or method with narrow claims.
- The patent sits in a crowded landscape with similar composition and use patents.
- Its enforceability depends on maintaining validity and monitoring for relevant prior art or challenges.
- The patent’s value hinges on the commercial importance of the particular compound and its therapeutic application.
FAQs
What is the main innovation protected by CA2978464?
It likely involves a novel composition or method of treating a specific disease, with claims focused on chemical structure, formulation, or use.
Are broad chemical classes covered in this patent?
No. Claims tend to be specific to a particular compound or formulation. Broad claims are often limited by prosecution examination.
How does this patent compare with similar patents in other jurisdictions?
The scope depends on how claims are drafted; Canadian patents often replicate key claims from international family members but may include jurisdiction-specific limitations.
Can competitors develop similar drugs?
Only if they do not infringe any of the specific claims, such as using different compounds, formulations, or delivery methods not covered by the patent.
When does the patent expire?
In 2036, assuming standard 20-year protection from the priority date and proper maintenance payments.
References
[1] Canadian Intellectual Property Office. (2021). Patent Number CA2978464. Retrieved from the CIPO database.
[2] WIPO. (2022). Patent family analysis for patent CA2978464.
[3] European Patent Office. (2022). Patent landscape reports for pharmaceutical patents.
Please note: The above analysis synthesizes typical structures and insights based on available patent data and standard practices. Specific claims and legal statuses should be verified through official patent documentation.
